Keith Sarbaugh - 18 Feb 2026 Form 4 Insider Report for Zoetis Inc. (ZTS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
19 Feb 2026, 20:53:54 UTC
Prior SEC filing
10 Feb 2026
Next SEC filing
23 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brenda Santuccio, as Attorney-in-Fact

Key filing fact

Keith Sarbaugh filed Form 4 for Zoetis Inc. (ZTS) on 19 Feb 2026.

Key facts

  • This page summarizes Keith Sarbaugh's Form 4 filing for Zoetis Inc. (ZTS).
  • 2 reported transactions and 8 derivative rows are listed below.
  • Accepted by SEC: 19 Feb 2026, 20:53.

Change

  • Previous filing in this sequence was filed on 10 Feb 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002044651 Primary reporting owner

Sarbaugh Keith

Relationship
Executive Vice President
Address
C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY
Signature
/s/ Brenda Santuccio, as Attorney-in-Fact
Signature date
19 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZTS transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+2,674
Change %
Price
$0.000000
Shares after
2,674
Date
18 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,674
Exercise price
Footnotes
F1, F2, F3, F4
ZTS transaction Derivative

Stock Option

Award

Transaction value
$0
Shares
+10,581
Change %
Price
$0.000000
Shares after
10,581
Date
18 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,581
Exercise price
$129.13
Footnotes
F8, F9, F10
ZTS holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,160
Date
18 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,160
Exercise price
Footnotes
F1, F2, F4, F5
ZTS holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
120
Date
18 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
120
Exercise price
Footnotes
F1, F2, F4, F6
ZTS holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,528
Date
18 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,528
Exercise price
Footnotes
F1, F2, F4, F7
ZTS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,453
Date
18 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,453
Exercise price
$156.64
Footnotes
F8, F10, F11
ZTS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,348
Date
18 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,348
Exercise price
$196.14
Footnotes
F8, F10, F12
ZTS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,142
Date
18 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,142
Exercise price
$166.44
Footnotes
F8, F10, F13
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 13 footnotes

Footnote F1

Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

Footnote F2

Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

Footnote F3

One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F4

Not applicable.

Footnote F5

One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F6

One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F7

One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, March 31, 2023; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F8

Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.

Footnote F9

One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 18, 2026.

Footnote F10

Each option expires on the tenth anniversary of the date of grant.

Footnote F11

One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 19, 2025.

Footnote F12

One-third of each option vests on the first, second and third anniversaries of the date of grant, February 6, 2024.

Footnote F13

One-third of each option vests on the first, second and third anniversaries of the date of grant, March 31, 2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .